Mark BLUMENKRANZ

Person

Menlo Park, CA, US

People

Patents Applicationslast 30 patents

Information Patent Application
TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
- Publication number 20220265740
- Publication date Aug 25, 2022
- Adverum Biotechnologies, Inc.
- Mark BLUMENKRANZ
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Topical Ocular Delivery Methods and Devices for Use in the Same
- Publication number 20190314196
- Publication date Oct 17, 2019
- Kedalion Therapeutics, Inc.
- Ehud Ivri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical Ocular Delivery Methods and Devices for Use in the Same
- Publication number 20190314197
- Publication date Oct 17, 2019
- Kedalion Therapeutics, Inc.
- Ehud Ivri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical Ocular Delivery Methods and Devices for Use in the Same
- Publication number 20190314198
- Publication date Oct 17, 2019
- Kedalion Therapeutics, Inc.
- Ehud Ivri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Topical Ocular Delivery Methods and Devices for Use in the Same
- Publication number 20190314195
- Publication date Oct 17, 2019
- Kedalion Therapeutics, Inc.
- Ehud Ivri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT
- Publication number 20190151409
- Publication date May 23, 2019
- Adverum Biotechnologies, Inc.
- Mark BLUMENKRANZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR REDUCING OCULAR NEOVASCULARIZATION
- Publication number 20190100582
- Publication date Apr 4, 2019
- Adverum Biotechnologies, Inc.
- Mark BLUMENKRANZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark BLUMENKRANZ

Person

Patents Applicationslast 30 patents

TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT

Topical Ocular Delivery Methods and Devices for Use in the Same

Topical Ocular Delivery Methods and Devices for Use in the Same

Topical Ocular Delivery Methods and Devices for Use in the Same

Topical Ocular Delivery Methods and Devices for Use in the Same

TREATMENT OF AMD USING AAV2 VARIANT WITH AFLIBERCEPT

COMPOSITIONS AND METHODS FOR REDUCING OCULAR NEOVASCULARIZATION